A Prospective Observational Cohort Study to Develop a Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT03939481

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:27:57.790142+00:00

Published At

2026-04-13T00:00:00+00:00

Record Updated At

2026-04-13

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Anatomic Stage I Breast Cancer AJCC v8", "Anatomic Stage IA Breast Cancer AJCC v8", "Anatomic Stage IB Breast Cancer AJCC v8", "Anatomic Stage II Breast Cancer AJCC v8", "Anatomic Stage IIA Breast Cancer AJCC v8", "Anatomic Stage IIB Breast Cancer AJCC v8", "Anatomic Stage III Breast Cancer AJCC v8", "Anatomic Stage IIIA Breast Cancer AJCC v8", "Anatomic Stage IIIB Breast Cancer AJCC v8", "Anatomic Stage IIIC Breast Cancer AJCC v8", "Lung Non-Small Cell Carcinoma", "Prognostic Stage I Breast Cancer AJCC v8", "Prognostic Stage IA Breast Cancer AJCC v8", "Prognostic Stage IB Breast Cancer AJCC v8", "Prognostic Stage II Breast Cancer AJCC v8", "Prognostic Stage IIA Breast Cancer AJCC v8", "Prognostic Stage IIB Breast Cancer AJCC v8", "Prognostic Stage III Breast Cancer AJCC v8", "Prognostic Stage IIIA Breast Cancer AJCC v8", "Prognostic Stage IIIB Breast Cancer AJCC v8", "Prognostic Stage IIIC Breast Cancer AJCC v8", "Stage I Lung Cancer AJCC v8", "Stage I Ovarian Cancer AJCC v8", "Stage IA Ovarian Cancer AJCC v8", "Stage IA1 Lung Cancer AJCC v8", "Stage IA2 Lung Cancer AJCC v8", "Stage IA3 Lung Cancer AJCC v8", "Stage IB Lung Cancer AJCC v8", "Stage IB Ovarian Cancer AJCC v8", "Stage IC Ovarian Cancer AJCC v8", "Stage II Lung Cancer AJCC v8", "Stage II Ovarian Cancer AJCC v8", "Stage IIA Lung Cancer AJCC v8", "Stage IIA Ovarian Cancer AJCC v8", "Stage IIB Lung Cancer AJCC v8", "Stage IIB Ovarian Cancer AJCC v8", "Stage III Lung Cancer AJCC v8", "Stage III Ovarian Cancer AJCC v8", "Stage IIIA Lung Cancer AJCC v8", "Stage IIIA Ovarian Cancer AJCC v8", "Stage IIIA1 Ovarian Cancer AJCC v8", "Stage IIIA2 Ovarian Cancer AJCC v8", "Stage IIIB Lung Cancer AJCC v8", "Stage IIIB Ovarian Cancer AJCC v8", "Stage IIIC Lung Cancer AJCC v8", "Stage IIIC Ovarian Cancer AJCC v8"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2026-04-13"

protocolSection.identificationModule.nctId

"NCT03939481"

protocolSection.identificationModule.officialTitle

"A Prospective Observational Cohort Study to Develop a Predictive Model of Taxane-Induced Peripheral Neuropathy in Cancer Patients"

protocolSection.statusModule.overallStatus

"ACTIVE_NOT_RECRUITING"

protocolSection.designModule.phases

[]

protocolSection.statusModule.resultsFirstPostDateStruct.date

""

Study condition terms

• Anatomic Stage I Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Anatomic Stage IA Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Anatomic Stage IB Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Anatomic Stage II Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Anatomic Stage IIA Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Anatomic Stage IIB Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Anatomic Stage III Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Anatomic Stage IIIA Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Anatomic Stage IIIB Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Anatomic Stage IIIC Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Lung Non-Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
• Prognostic Stage I Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Prognostic Stage IA Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Prognostic Stage IB Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Prognostic Stage II Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Prognostic Stage IIA Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Prognostic Stage IIB Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Prognostic Stage III Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Prognostic Stage IIIA Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Prognostic Stage IIIB Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Prognostic Stage IIIC Breast Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage I Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage I Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IA Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IA1 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IA2 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IA3 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IB Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IC Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage II Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage II Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIA Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIA Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIB Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage III Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA1 Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIA2 Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIB Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIC Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
• Stage IIIC Ovarian Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.